Saturday 17 October 2026
Export TMDX’s income statement to Excel — free account
TransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.7%, EPS fell 59.2%, free cash flow fell 87.6% and total debt rose 68.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
70.78
5.74
−7.50%
Follow TMDX
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 6 | 3 | 3 | 4 | 4 | — | — | — | — |
P/E ratio |
21.80 | 58.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
6.83 | 4.69 | 10.34 | 18.06 | 17.49 | 19.17 | 11.44 | 2.09 | 2.09 | 2.09 |
Altman Z-Score |
5.32 | 2.70 | 2.69 | 10.73 | 0.25 | 3.12 | (1.46) | — | — | — |
P/FCF ratio |
30.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
4.04 | 2.40 | 1.89 | 1.21 | (6.95) | (1.62) | (6.97) | (25.87) | — | — |
Beneish M-Score |
(1.32) | (1.95) | (1.21) | (0.04) | 2.05 | (2.46) | (2.12) | — | — | — |
P/Operating CF |
119.82 | 105.37 | 300.74 | (418.33) | (79.59) | (68.87) | (37.17) | (4.36) | (4.36) | (4.36) |
P/B ratio |
8.74 | 9.06 | 18.20 | 9.01 | 7.80 | 4.73 | 4.94 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
9.00 | 9.64 | 20.33 | 9.01 | 7.80 | 4.73 | 4.94 | 0.00 | 0.00 | 0.00 |
EV/Sales |
6.87 | 5.09 | 10.80 | 16.55 | 15.59 | 15.62 | 9.47 | 3.51 | 3.51 | 3.51 |
EV/EBITDA |
30.64 | 39.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
21.57 | 46.03 | (200.39) | (33.76) | (16.35) | (13.24) | (6.92) | (1.98) | (1.98) | (1.98) |
EV/FCF |
31.14 | (27.76) | (13.59) | (26.80) | (14.57) | (13.04) | (6.89) | (1.95) | (1.95) | (1.95) |
Quick Ratio |
6.41 | 7.25 | 8.34 | 9.67 | 4.23 | 11.15 | 5.41 | 1.89 | 2.35 | — |
Current Ratio |
7.14 | 8.30 | 9.30 | 10.66 | 5.11 | 12.36 | 6.21 | 2.77 | 3.12 | — |
Net Debt/EBITDA |
0.18 | 3.02 | (5.42) | 5.04 | 1.52 | 3.67 | 1.64 | (0.69) | 0.81 | 0.00 |
Debt/Assets |
47.96% | 63.34% | 71.70% | 21.70% | 26.09% | 22.80% | 32.43% | 79.87% | 0.00% | — |
Debt/Equity |
1.08 | 2.23 | 3.69 | 0.32 | 0.52 | 0.33 | 0.62 | (5.88) | 0.49 | — |
Asset Turnover |
0.65 | 0.58 | 0.49 | 0.45 | 0.21 | 0.20 | 0.32 | 0.62 | 0.19 | 0.00 |
Operating CF/Net income |
1.01 | 1.38 | 0.52 | 1.26 | 0.65 | 1.05 | 0.96 | 1.09 | 1.11 | 1.01 |
Capex/Depreciation |
(2.18) | (6.57) | (21.90) | (3.42) | (1.94) | (0.29) | (0.13) | (0.54) | 0.00 | 0.00 |
Interest Coverage |
7.88 | 2.60 | (2.66) | (8.44) | (10.18) | (6.62) | (6.80) | (7.44) | (29.78) | (42.61) |
| 54.24% | 19.39% | (15.42%) | (28.39%) | (51.49%) | (36.27%) | 48.76% | 13.16% | 11.54% | 0.00% | |
| 20.33% | 4.70% | (5.09%) | (17.59%) | (30.82%) | (22.34%) | (45.50%) | (112.70%) | (52.61%) | 0.00% | |
ROIC |
13.65% | 5.84% | (7.22%) | (42.41%) | (232.50%) | (127.77%) | (228.22%) | (164.13%) | 0.00% | — |
Return on Tangible Assets |
21.72% | 4.90% | (3.97%) | (14.62%) | (41.99%) | (20.59%) | (37.83%) | (92.38%) | (81.35%) | 0.00% |
Average Days of Receivables |
50.81 | 80.78 | 96.04 | 107.83 | 71.57 | 97.72 | 101.43 | 96.40 | 43.93 | 0.00 |
Research and Development Expense of Revenue |
11.40% | 12.68% | 26.18% | 28.69% | 73.70% | 73.45% | 84.18% | 104.91% | 194.63% | 251.84% |
Selling, General and Administrative Expense of Revenue |
30.58% | 38.19% | 49.48% | 74.79% | 126.51% | 94.34% | 99.97% | 94.61% | 95.98% | 127.06% |
Intangible Assets out of Total Assets |
0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Share Based Compensation of Revenue |
6.09% | 7.52% | 8.19% | 11.04% | 22.73% | 9.42% | 3.62% | 1.11% | 0.00% | 0.00% |
Graham Net Nets |
0.01 | (0.04) | (0.02) | 0.10 | 0.10 | 0.20 | 0.18 | (0.67) | (0.67) | (0.67) |
Graham Number |
41.80 | 12.87 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 235.88 | 0.00 | 0.00 |
Earnings Yield |
4.59% | 1.72% | (1.00%) | (2.19%) | (8.40%) | (6.03%) | (33.56%) | (83.78%) | (83.78%) | (83.78%) |
Free Cash Flow Yield |
3.23% | (3.91%) | (7.69%) | (3.42%) | (6.12%) | (6.25%) | (12.02%) | (86.10%) | (86.10%) | (86.10%) |
Revenue per Share |
17.81 | 13.29 | 7.43 | 3.16 | 1.10 | 1.04 | 1.66 | 9.58 | 0.39 | 0.31 |
Operating CF per Share |
5.67 | 1.47 | (0.40) | (1.55) | (1.05) | (1.23) | (2.27) | (19.12) | (1.16) | (1.21) |
Capex per Share |
(1.74) | (3.90) | (5.51) | (0.40) | (0.13) | (0.02) | (0.01) | (0.31) | 0.00 | 0.00 |
Free Cash Flow per Share |
3.93 | (2.44) | (5.91) | (1.95) | (1.17) | (1.24) | (2.28) | (19.43) | (1.16) | (1.21) |
Cash per Share |
14.37 | 10.13 | 12.14 | 6.81 | 3.35 | 5.09 | 5.68 | 14.89 | 1.24 | 0.00 |
Shareholders Equity per Share |
13.92 | 6.88 | 4.22 | 6.34 | 2.46 | 4.21 | 3.85 | (4.21) | 0.89 | 0.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
13.92 | 6.88 | 4.22 | 6.34 | 2.46 | 4.21 | 3.85 | (4.21) | 0.89 | 0.00 |
Free Cash Flow |
133.59 | (80.94) | (192.09) | (57.72) | (32.38) | (30.72) | (32.45) | (26.40) | (23.10) | (24.19) |
Working Capital |
548.48 | 437.30 | 455.72 | 228.63 | 95.47 | 134.89 | 83.89 | 22.24 | 23.14 | — |
Capital Expenditures |
(59.25) | (129.74) | (179.06) | (11.91) | (3.52) | (0.45) | (0.16) | (0.42) | (0.26) | (1.48) |
Net Current Asset Value |
42.51 | (78.26) | (58.19) | 162.52 | 51.67 | 98.63 | 49.35 | (13.09) | 14.83 | — |
EV/EBIT |
38.31 | 59.91 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.10 | 0.29 | 0.74 | 0.13 | 0.12 | 0.02 | 0.01 | 0.03 | 0.00 | 0.00 |
Price to Operating Income |
38.08 | 55.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.08 | 0.07 | 0.05 | 0.18 | 0.18 | 0.33 | 0.26 | 0.22 | 0.26 | 0.00 |
Cash ROIC |
9.06% | (7.53%) | (18.50%) | (12.86%) | (16.56%) | (11.63%) | (19.15%) | (54.79%) | (45.19%) | 0.00% |
Accounts Receivable Turnover |
6.65 | 5.47 | 5.30 | 5.57 | 4.73 | 3.82 | 4.72 | 5.97 | 3.52 | 0.00 |
Accounts Payable Turnover |
23.51 | 15.60 | 10.90 | 5.64 | 2.32 | 2.13 | 1.63 | 1.77 | 2.52 | 2.48 |
Inventory Turnover |
5.09 | 3.95 | 2.70 | 1.59 | 0.68 | 0.78 | 0.95 | 0.84 | 1.81 | 1.78 |
Average Days of Payables |
15.57 | 20.93 | 53.03 | 43.26 | 266.68 | 48.89 | 271.55 | 236.55 | 222.04 | 68.38 |
Days of Inventory on Hand |
73.52 | 94.69 | 184.46 | 266.82 | 595.80 | 483.78 | 420.27 | 464.93 | 503.53 | (102.18) |
Average Receivables |
91.00 | 80.65 | 45.59 | 16.77 | 6.40 | 6.71 | 5.00 | 2.18 | 2.18 | — |
Average Payables |
10.32 | 11.50 | 8.03 | 5.00 | 3.93 | 4.23 | 5.98 | 4.12 | 2.29 | 2.29 |
Average Inventory |
47.72 | 45.39 | 32.42 | 17.73 | 13.40 | 11.58 | 10.25 | 8.62 | 3.19 | 3.19 |
Average Assets |
936.22 | 755.06 | 491.60 | 206.02 | 143.46 | 128.66 | 73.73 | 21.08 | 39.58 | — |
Average Common Equity |
350.85 | 182.90 | 162.29 | 127.61 | 85.87 | 79.27 | (68.80) | (180.48) | (180.48) | — |
Columns are period end dates